Funded Tech Companies
AnBogen Therapeutics
Wondering who provided funding to AnBogen Therapeutics? Maxpro Ventures, National Development Fund of Taiwan and TaiAn Technologies joined the equity holders in this healthcare services company.
Company Overview
Company Name
AnBogen Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
No.99, Lane 130, Sec. 1, Research Institute Road, Nangang Di C523
Taipei, 11571
Taiwan
Taipei, 11571
Taiwan
Phone
Website
Email Address
Company Background Information
Overview
Anbogen Therapeutics is a clinical-stage biotech company designing and developing precision oncology therapies to improve the life of patients. Founded by a group of exceptional scientists from National Health Research Institute, the most prestigious medical research institute in Taiwan, we are devoted to bringing the gap between research and clinical development and dedicated to creating breakthrough science that changes the life of cancer patients.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/1/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tsu-An Hsu
President
Joe Hsueh
VP - Bus. Development
Chun-Hsuan Lo
VP - Bus. Development
Kien-Thiam Tan
VP - Bus. Development
Angus Tsung-Kai Wu
VP - Finance
Endy Yang
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs